Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE PCSK7 variant rs236918 is a risk factor for cirrhosis in HH patients homozygous for the HFE C282Y mutation. 24556216

2014

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Liver iron overload and C282Y mutation are associated with a higher risk of HCC in patients with alcoholic but not HCV-related cirrhosis. 18061182

2008

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Among Caucasians, C282Y heterozygotes were more likely to have bridging fibrosis or cirrhosis (44% versus 21% [P = 0.05]) and stainable hepatic iron (50% versus 16% [P = 0.011]) compared with patients with other genotypes. 17680648

2007

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE C282Y or H63D heterozygosity is an independent risk factor for liver fibrosis and cirrhosis in HCV infected individuals. 12586300

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE The aims of this study were to define the prevalence of the mutations 845G --> A and 187C --> G (C282Y and H63D) in the HFE gene associated with hereditary hemochromatosis in Italian patients with hepatocellular carcinoma occurring in cirrhosis and to analyze the interaction between these mutations and other established risk factors for hepatocellular carcinoma. 11500061

2001

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE C282Y and H63D mutations do not appear to be associated with an increased risk of HCC in patients with cirrhosis. 12865278

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Other recent evidence indicates that the prevalence of HFE gene mutations is increased in chronic viral hepatitis and that patients with chronic hepatitis C harboring especially the C282Y mutation are more likely to suffer from advanced hepatic fibrosis or cirrhosis and to do so at younger ages. 12957298

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE An elevated SF >1000 mg/l [corrected] is associated with an increased risk of cirrhosis and mortality in C282Y homozygotes.Conversely, a SF <1000 µg/l is associated with a very low likelihood of cirrhosis, making liver biopsy unnecessary among C282Y homozygotes in the absence of concomitant risk factors for liver disease. 23985001

2013

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Only the homozygous C282Y mutation seems to occur more frequently in the selected population of patients with liver cirrhosis. 21669570

2011

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? 11232708

2001

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Only a minority of our patients with hemochromatosis had a far advanced disease at the time of diagnosis (less than 5% had cirrhosis) and hemochromatosis in a majority of the C282Y mutation negative patients was associated with excessive oral iron intake for several years. 11199371

2000

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE None of the 12 C282Y homozygotes had cardiac dysfunction or hepatic cirrhosis. 12482402

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE The aim of this study was to investigate the association between HFE gene mutations (C282Y, H63D) and hepatocellular carcinoma in patients with alcoholic and virus-related cirrhosis. 12003382

2002

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE The C282Y and the H63D mutation of the HFE gene were analyzed in 137 patients with HCC and no history of HH, 107 patients with cirrhosis without HCC and 126 healthy controls. 15017669

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Heavy HIOL was noted in C282Y homozygotes and 1 patient with cirrhosis without either HFE mutation. 12109859

2002

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE A diagnosis of liver cancer or cirrhosis is rare in the lifetime of individuals from this population who are homozygous for the C282Y mutation (2.5%; upper 95% confidence interval (CI) = 8%). 10673304

2000

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Patients with HH carrying the HFE gene who were homozygous for the Cys282Tyr mutation, serum ferritin levels of 300-2000 ng/mL, transferrin saturation ≥ 45%, and no known history of cirrhosis were enrolled in this dose-escalation study to characterize the safety and efficacy of deferasirox, comprising a core and an extension phase (each 24 weeks). 20814896

2010

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Most clinical cases are homozygous for the Cys282Tyr (C282Y) mutation in the HFE gene, with serum ferritin (SF) concentration >1000 microg/L as the strongest predictor of cirrhosis. 20583211

2010

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE For C282Y heterozygous patients, the odds ratios for marked inflammatory activity (A2-4) and advanced liver fibrosis or cirrhosis (F2-4) are 4.9 and 4.6, respectively, compared with patients carrying homozygous wild-type alleles. 15287851

2004

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Liver biopsy is recommended when ferritin exceeds 1000 microg/l to establish the presence or absence of cirrhosis, which will affect prognosis and management. iron accumulation confirmed by magnetic resonance imaging (MRI) in the absence of the homozygous C282Y mutation or the combined C282Y/H63d genotype may justify a search for rare hereditary forms of non-HFE HH in a specialised centre. 18079569

2007

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE In HCV-infected patients, heterozygosity for the C282Y mutation in HFE was significantly associated with elevated serum ferritin levels, stainable liver iron, and advanced fibrosis or c</span>irrhosis (F2-F4). 14557859

2003

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE In hemochromatosis probands homozygous for HFE C282Y, serum levels of ferritin greater than 1000 μg/L at diagnosis were positively associated with male sex and cirrhosis. 22265917

2012

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE Hereditary hemochromatosis (HH), most often due to HFE C282Y homozygosity, is an iron overload disorder that can result in severe morbidity including hepatic cirrhosis. 19930418

2010

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE The results indicate that HH patients with the HFE C282Y mutation and low numbers of CD8+ cells in the liver lobuli have higher iron stores and are more prone to develop liver cirrhosis. 11168438

2001

dbSNP: rs1800562
rs1800562
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.100 GeneticVariation BEFREE In conclusion, cirrhosis in HFE p.C282Y homozygotes is significantly associated with age, diabetes, daily alcohol intake, and iron removed by phlebotomy, taking into account the effect of other variables. 30145563

2018